Functionalised benzopyran compounds and use thereof
The present invention relates broadly to anti-cancer agents. In particular, the present invention relates to selected benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence.
1. A compound selected from the group consisting of:
and pharmaceutically acceptable salts thereof.
2. A pharmaceutical composition comprising the compound according to claim 1 together with a pharmaceutically acceptable carrier, diluent or excipient.
3. A method for the treatment of cancer in a subject in need thereof, the method comprising administration to the subject of a therapeutically effective amount of the compound according to claim 1 .
4. The method of claim 3 , wherein the cancer is a cancer that has recurred.
5. The method of claim 3 , wherein the cancer is resistant to one or more chemotherapeutic agents.
6. The method of claim 3 , wherein the cancer is selected from the group consisting of: pancreatic cancer, colorectal cancer, melanoma, prostate cancer, brain cancer (including paediatric and adult), ovarian cancer, breast cancer, lung cancer, liver cancer, uterine cancer, neuroblastoma, mesothelioma, malignant ascites and peritoneal cancer.
7. A method for reducing incidences of, or risk of, cancer recurrence in a subject deemed to be at risk of cancer recurrence, the method comprising administration to the subject of an effective amount of the compound according to claim 1 .
8. The method of claim 7 , wherein the subject deemed to be at risk of cancer recurrence is a subject who is in cancer remission.
9. The method of claim 8 , wherein the subject is in remission from ovarian cancer or brain cancer.
10. The method of claim 6 , wherein the cancer is ovarian cancer or brain cancer.
11. The method of claim 6 , wherein the cancer is brain cancer.
12. The method of claim 11 , wherein the brain cancer is glioma.